PROphet
®
PROphetNSCLC
®
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical studies
Collaborators
About Us
News
In the news
Thought Leadership
Press releases
Meetings & Events
Awards
Contact Us
Careers
US openings
Israel openings
Order a test
PROphet
®
PROphetNSCLC
®
Test
PROphet
®
Technology
Resources
For Patients
For Providers
For Pharma
Science
Publications
Presentations
Clinical Studies
Collaborators
News
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
Company
About us
Careers
Contact us
Order a test
In the News
Thought Leadership
Press Releases
Meetings & Events
Awards
September 20, 2021
OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Original source
here.
Recent news
November 7, 2025
OncoHost wins Proteomics Innovation of the Year for PROphet platform
Read more
November 6, 2025
Israeli Startup OncoHost Wins Global Award for Proteomics Innovation
Read more
November 6, 2025
OncoHost Wins ‘Proteomics Innovation of the Year’ at the BioTech Breakthrough Awards
Read more
November 2, 2025
OncoHost Showcases Innovative Insights in NSCLC Proteomics
Read more
November 2, 2025
OncoHost to Present Two Posters Highlighting Advances in Plasma Proteomics Monitoring and Prediction for NSCLC at ISLB 2025
Read more
November 2, 2025
OncoHost Advances Plasma Proteomics for NSCLC Immunotherapy Monitoring and Prediction
Read more
Read all news